Skip to content Skip to footer

Inclusiveness Target Country (ITC) Conference Grants

Mission Period: 20 March 2025 – 30 September 2025

Are you a Researcher or Innovator from an ITC Country? Would you like to attend an international conference to present your work?

Click for more details

SIGMA-1 EUROPE is offering ITC Conference Grants (of up to €2,000 each) to researchers and innovators to attend a high-level conference and present their work as an oral presentation. To be eligible you must be affiliated to a legal entity in a COST ITC or Near Neighbour Country. The work presented must be relevant to the scope of the Action. The grant can provide a contribution to travel, accommodation and subsistence expenses, registration fees and overall effort.
Note the ITC Conference Grants are now available to researchers/innovators of any age and are no longer restricted to Young Researchers under 40 years old. They now provide support for people accepted to give an oral presentation but not a poster.

Important Dates
Call closes: 30 September 2025
Notification of Results: 2 weeks after submission of complete application
Mission Period: 20 March 2025 – 30 September 2025
Please note: This is an open call. You can apply any time up to 15 September 2025 for your ITCCG to start and end within the call period (20 March 2025 to 30 September 2025). Please ensure there is at least one month between submitting your application and the start date of the conference.

What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

COST ACTION CA23156

The SIGMA-1 EUROPE Action is dedicated to promoting excellence in research and innovation related to sigma-1 receptor physiopathology and therapeutic applications across multiple fields. This initiative fosters interdisciplinary collaboration to drive breakthrough science and technological advancements in medicinal chemistry and pharmaceutical development.

Action Details

Action Start Date: October 25, 2024
Action End Date: October 24, 2028

© 2025. All rights reserved. – Privacy PolicyPrivacy settings

Created by elaboranext